Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-ITGAV&ITGB3, CNTO 095 Vector   (CAT#: GTVCR-WQ1010MR)

This product GTVCR-WQ1010MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting ITGAV&ITGB3. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Homo sapiens
RefSeq NM_001144999.3; NM_000212.3
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 3685; 3690
UniProt ID P06756; P05106
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-ITGAV&ITGB3, CNTO 095 Vector (GTVCR-WQ1010MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1716MR IVTScrip™ pT7-VEE-mRNA-Anti-MS4A1, LFB-R603 Vector Vector LFB-R603
GTVCR-WQ141MR IVTScrip™ pSP6-VEE-mRNA-Anti-AXL, Ab-2 Vector Vector Ab-2
GTVCR-WQ2274MR IVTScrip™ pSP6-VEE-mRNA-Anti-IL13, QAX-576 Vector Vector QAX-576
GTVCR-WQ2632MR IVTScrip™ pT7-VEE-mRNA-Anti-SEMA4D, VX-15 Vector Vector VX-15
GTVCR-WQ679MR IVTScrip™ pT7-VEE-mRNA-Anti-IL23A, BI 655066 Vector Vector BI 655066
GTVCR-WQ1770MR IVTScrip™ pSP6-VEE-mRNA-Anti-IL23A, LY­3074828 Vector Vector LY­3074828
GTVCR-WQ1868MR IVTScrip™ pT7-VEE-mRNA-Anti-IFNAR1, MDX-1333 Vector Vector MDX-1333
GTVCR-WQ1936MR IVTScrip™ pT7-VEE-mRNA-Anti-CD276, MG-A271 Vector Vector MG-A271
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.